The BCAP31 expression was demonstrated to be substantially linked with poor OS in many cancer types, including brain lower grade glioma (BLGG) (p < 0.001), HNSC (p < 0.001), BRCA (p = 0.001), glioblastoma multiforme (GBM) (p < 0.011), acute myeloid leukemia (LAML) (p = 0.022), ESCA (p = 0.032), and LUAD (p = 0.035) (Figure 4A). Here, BCAP31 is linked to cancer.